sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Next Generation Cancer Diagnostics Market Scope And Analysis

  • Report Code : TIPRE00006920
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Next Generation Cancer Diagnostics Market Analysis, Trends, and Scope 2025 to 2031

Buy Now

Next Generation Cancer Diagnostics Market Report Next Generation Cancer Diagnostics Market Size and Share Next Generation Cancer Diagnostics Market Scope and Analysis

Next Generation Cancer Diagnostics Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) XX%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Technology
  • QPCR and Multiplexing
  • Benchtop Sequencers
  • Lab-on-a-chip
  • Next Generation Sequencing
  • Protein Microarrays
  • DNA Microarrays
By Application
  • Biomarker Development
  • Proteomic Analysis
  • CTC Analysis
  • Genetic Analysis
  • Epigenetic Analysis
By Cancer Type
  • Lung Cancer
  • Colorectal Cancer
  • Breast Cancer
  • Prostate Cancer
By Function
  • Cancer Screening
  • Therapeutic Monitoring
  • Prognosis Diagnostics
  • Risk Analysis
  • Companion Diagnostics
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Agilent Technologies Inc
  • Illumina Inc
  • PerkinElmer Inc
  • F Hoffmann La Roche Ltd
  • GENERAL ELECTRIC
  • OPKO Health Inc
  • QIAGEN
  • Thermo Fisher Scientific Inc
  • Abbott